[1]
P. Subramanian, “Assessing Provider Utilization of COVID-19 Inflammatory Marker Trends in Hospitalized Patients and Implications in Optimizing Value-Based Care During a Pandemic”, kjm, vol. 15, no. 1, pp. 91–96, Mar. 2022.